Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: A cross-sectional study in a low cardiovascular disease risk geographical area - 20/10/09
, F. Cañas b, J.R. Banegas c, J. Casademont d, Y. Riesgo e, C. Varela eOn behalf of the RICAVA Study Group
Corresponding author.Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
| páginas | 11 |
| Iconografías | 2 |
| Vídeos | 0 |
| Otros | 0 |
Abstract |
Objective |
Prevalence of cardiovascular disease is high in schizophrenia. Our aim is to estimate the prevalence of cardiovascular risk factors (CVRF) among schizophrenia patients.
Method |
National cross-sectional study in patients diagnosed with schizophrenia under treatment with second generation antipsychotics and admitted to short-stay hospitalisation units.
Results |
A sample of 733 consecutively admitted patients was enrolled; the most prevalent CVRFs were smoking 71% (95% CI: 67–74%) and hypercholesterolemia 66% (61–70%) followed by hypertriglyceridemia 26% (26–32%), hypertension 18% (15–21%) and diabetes 5% (4–7%). Metabolic syndrome showed 19% (95% CI: 16–23%) prevalence or, according to updated definitions (Clin Cornerstone 7 [2005] 36–45), 24% (95% CI: 20–28%). The rate of patients within the high-risk range of a 10-year fatal cardiovascular event was 6.5%. CVRFs under routine management were diabetes (60%), hypertension (28%) and, to a lesser extent, dyslipemia (14%). Treatment for CVRFs was associated to gender, men for hypertension OR=25.34, p<0.03 and women for diabetes OR=0.02, p<0.03.
Conclusion |
We found that CVRFs in schizophrenia were prevalent and under-diagnosed, and thus with insufficient therapeutic management.
El texto completo de este artículo está disponible en PDF.Keywords : Risk factors, Schizophrenia, Disease management, Physical health, Comorbidity
Esquema
 | Some of the results of this study were presented in poster form at the Thirteenth Biennial Winter Workshop on Schizophrenia, Davos, Switzerland, 4–10 February 2006; 2006 American Psychiatric Association Annual Meeting, Toronto, Canada, May 20–25, 2006. |
Vol 24 - N° 7
P. 431-441 - octobre 2009 Regresar al número
Artículo precedente
- Serious diabetes-specific emotional problems in patients with type 2 diabetes who have different levels of comorbid depression: A Polish study from the European Depression in Diabetes (EDID) Research Consortium
- A. Kokoszka, F. Pouwer, A. Jodko, R. Radzio, P. Mućko, J. Bieńkowska, E. Kuligowska, O. Smoczyńska, Z. Skłodowska
- Personality problems are considerably associated with somatic morbidity and health care utilisation
- I. Olssøn, A.A. Dahl
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?